Objective
febrile neutropenia, acute leukemia
FEBRILE NEUTROPENIA, ACUTE LEUKEMIA
The main objective of this clinical trial is to demonstrate non-inferiority in efficacy of oral fosfomycin versus oral ciprofloxacin in preventing febrile neutropenia in patients with acute leukemia treated with intensive chemotherapy and/or recipients of hematopoietic stem cell transplantation.